1. Market Research
  2. > Pharmaceutical
  3. > Therapy Market Trends
Global CRISPR Technology Market - Analysis And Forecast (2018-2027)

Global CRISPR Technology Market - Analysis And Forecast (2018-2027)

  • April 2018
  • 335 pages
  • ID: 5381407
  • Format: PDF
  • By BIS Research

Summary

Table of Contents

Global CRISPR Technology Market Expected to Reach $10.55 Billion by 2027

The CRISPR technology industry is focused on the development of gene therapeutics for the treatment of various genetic disorders such as thalassemia, haemophilia, and sickle cell anaemia, among others. The increasing prevalence of genetic disorders is promoting the growth of the CRISPR technology, for better treatment and improved quality of life of patients.

The CRISPR technology include designing tools, library, control kits, plasmids, vectors, proteins, gRNA and other products to perform the desired experiment and study the obtained results.Currently, CRISPR technology is considered a valuable tool for the biotechnology and biopharmaceutical companies to conduct cost effective and highly efficient genome editing procedures.

Moreover, advancements of CRISPR technology reduced turn-around time and complexity of genome editing process.The CRISPR technology provides several opportunities to develop the one-time treatment for various rare genetic disorders.

The pharmaceutical industry is witnessing the growth of pipeline of candidates developed using CRISPR technology.Several biopharmaceutical companies are now indulging in the research and development of such CRISPR based therapies.

Furthermore, the advent of genome editing technologies in molecular research has enabled the companies to target the root cause of genetic and chronic diseases, with one-time procedure and develop gene therapeutics to remain competitive in the market.

The purpose of this study is to gain a holistic view of the CRISPR technology market in terms of various influencing factors, such as recent trends, regulatory requirements, and technological advancements of the market.The scope of this report constitutes a detailed study of the products associated with the global CRISPR technology market, across different regions.

The market has been segmented into ‘product’, ‘application’, and ‘regions’.The report presents the reader with an opportunity to unlock comprehensive insights with respect to the market and helps in forming well-informed strategic decisions.

The research uncovers some of the substantial parameters that must be taken into consideration before entering into the market.

This research report aims at answering various aspects of the global CRISPR technology market with the help of the key factors driving the market, restraints and challenges that can possibly inhibit the overall market growth, and the current growth opportunities that are going to shape the future trajectory of the market expansion.The report includes an in-depth examination of the key players and recent developments taking place in this market.

Moreover, the report includes chapters on market dynamics (market drivers, opportunities and challenges) and industry analysis as well.

The research study highlights the factors governing the industry attractiveness with Porter’s Five Forces for a comprehensive understanding of the global CRISPR technology market. Moreover, the study includes detailed product mapping with further sub-segmentation in various countries, and in each sub-segment the key market trends, list of the key companies, and the key strategies and developments, have been discussed.

The answers to the following key questions can be derived from this report:
• How did the CRISPR technology market evolve, and what is its scope in the future?
• What are the major market drivers, challenges and opportunities in the global CRISPR technology market?
• What are the key developmental strategies that are being implemented by the key players to sustain in this market?
• How are the influencing factors will affect the industry attractiveness?
• How the CRISPR technology is being utilized for the development of therapeutics?
• How the investments by public & private companies, and government organizations will affect the global CRISPR technology market?
• What was the market size of the leading segments and sub-segments of the global CRISPR technology market in 2017?
• How will the industry evolve during the forecast period 2018- 2027?
• What will be the growth rate of the CRISPR technology during the forecast period?
• How will each segment of the global CRISPR technology market grow during the forecast period and what will be the revenue generated by each of the segments by the end of 2027?
• Which product segment, and application segment is expected to register the highest CAGR for the CRISPR technology market?
• What are the major benefits of the implementation of CRISPR technology in different field of applications including biological research, agricultural biotech, industrial biotech, and therapeutics & drug discovery?
• What is the market size of CRISPR technology in different countries of the world?
• Which geographical region will contribute to the highest sales of CRISPR technology?
• Who are the key players in the CRISPR technology market and what are their contributions?

The key players who have been contributing significantly to the CRISPR technology market include Agilent Technologies, Inc., Applied StemCell, Inc., Cellecta, Inc., Horizon Discovery plc, EdiGene, Inc., GeneCopoeia, Inc., Genedata AG, GeneScript, Integrated DNA Technologies (IDT), Inc., Mirus Bio LLC, New England Biolabs, OriGene Technologies, Inc., Oxford Genetics Ltd., Rockland Immunochemicals, Inc., Merck KGaA, Synthego Corporation, System Biosciences, LLC, Takara Bio Inc., Thermo Fisher Scientific, transOMIC technologies inc., and Transposagen Biopharmaceuticals, among others.

Executive Summary
Every year, around 7.9 million children are born with genetic disorders, worldwide. Also, the genetic diseases have been responsible for 20-30% of the infant’s deaths worldwide and constitute approximately 25% of the global economic burden for diseases. The increasing economic burden of genetic diseases can be reduced by focusing on gene therapeutics supported by biomarker study, lifestyle modification, and disease screening methods that enable early detection. Furthermore, the increasing environmental factors, such as chemical factors, radioactive factors, and biological factors, has elevated the mutation rate, which elevated the need for the development of best gene therapeutic procedures, personalized medicine, and diagnostic procedures with less turnaround time.

Several conglomerate companies and startups based out of the developed countries, such as the U.S., the U.K., Germany, China, France, and Canada, among others, have been making significant investments in the field of life sciences to develop promising gene therapy procedures to promote global health. The advent of CRISPR technology has transformed the field of genome editing by reducing the turnaround time and complexity, enhancing the accuracy, efficiency, and safety, and encouraged numerous innovations. Researchers demonstrated the potential applications of CRISPR technology to provide one-time gene therapy procedure for several genetic disorders, such as haemophilia, sickle cell anemia, and beta thalassemia, and cancers. Also, the CRISPR technology proved to repair genetic errors in an individual’s DNA, treating the root cause of the disease. Many companies, such as CRISPR Therapeutics AG, are planning to initiate clinical trials in 2018 for the treatment of various genetic disorders.

The purpose of the study is to gain a holistic view of the CRISPR technology market in terms of various factors influencing it such as recent trends and technological advancements of the market.The scope of this report is centered upon conducting a detailed study of the products associated with the global CRISPR technology market, across different regions.

The global CRISPR technology market is segmented into three different parts namely by product, by application, and by region.The global market value was estimated using these three different approaches and was validated with one another.

The global CRISPR technology market is expected to reach $10.55 billion by 2027.

With the increasing demand for advancements in application specific products across the various segments of the CRISPR technology, the CRISPR technology market is expected to witness rapid growth in the future. Further, the swift expansion of the gene therapy procedures in the developed markets such as the U.S., Japan, Germany, and the U.K. is the key driver for growth of the CRISPR technology market. Moreover, the plasmids sub-segment dominated the global CRISPR technology market in 2017 in terms of products. However, the proteins sub segment is anticipated to witness the highest CAGR during the forecast period. The therapeutics and drug discovery application specific CRISPR technology witnessed the highest industry demand. Besides, the CRISPR technology specific to industrial biotech are also expected to witness impressive CAGR during the forecast period.

Based on the region the global CRISPR technology market is segmented into North America, Europe, Asia Pacific and Rest of the World (RoW).North America is the leading contributor to the global CRISPR technology market and contributed 39% of the global market values in 2017.

However, Europe is expected to grow at a CAGR of 36.80% during the forecast period followed by Asia Pacific region.

The key players who have significant contributions to the global CRISPR technology market are Agilent Technologies, Inc., Applied StemCell, Inc., Cellecta, Inc., Horizon Discovery plc, EdiGene, Inc., GeneCopoeia, Inc., Genedata AG, GeneScript, Integrated DNA Technologies (IDT), Inc., Mirus Bio LLC, New England Biolabs, OriGene Technologies, Inc., Oxford Genetics Ltd., Rockland Immunochemicals, Inc., Merck KGaA, Synthego Corporation, System Biosciences, LLC, Thermo Fisher Scientific, transOMIC technologies inc., and Transposagen Biopharmaceuticals, among others.

Countries Covered
• North America
• U.S.
• Canada
• Europe
• U.K.
• Germany
• France
• Spain
• Italy
• Switzerland
• Rest of the Europe
• Asia Pacific
• Japan
• China
• South Korea
• Singapore
• India
• RoW

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 150+ Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
10% Off

($4599)

  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.
Ahmad helps you find the right report:
Testimonials

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at
Ikea

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at
Ingredion

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

FAQ
  • How we can help
    • I am not sure if the report I am interested in will fulfill my needs. Can you help me?
    • Yes, of course. You can call us at +33(0) 4 37 65 17 03 or drop us an email at researchadvisor@reportlinker.com to let us know more about your requirements.
    • We buy reports often - can ReportLinker get me any benefits?
    • Yes. Set up a call with a Senior Research Advisor to learn more - researchadvisor@reportlinker.com or +33(0) 4 37 65 17 03.
    • I have had negative experiences with market research reports before. How can you avoid this from happening again?
    • We advise all clients to read the TOC and Summary and list your questions so that we can get more insight for you before you make any purchase decision. A research advisor will accompany you so that you can compare samples and reports from different sources, and choose the study that is right for you.

  • Report Delivery
    • How and when I will receive my Report?
    • Most reports are delivered right away in a pdf format, while others are accessed via a secure link and access codes. Do note that sometimes reports are sent within a 12 hour period, depending on the time zones. However, you can contact us to escalate this. Should you need a hard copy, you can check if this option is offered for the particular report, and pay the related fees.
  • Payment conditions
    • What payment methods do you accept?
      1. Credit card : VISA, American Express, Mastercard, or
      2. You can download an invoice to pay by wire transfer, check, or via a Purchase Order from your company, or
      3. You can pay via a Check made out in US Dollars, Euros, or British Pounds for the full amount made payable to ReportLinker
    • What are ReportLinker’s Payment Terms?
    • All payments must normally be submitted within 30 days. However, you can let us know if you need extended time.
    • Are Taxes and duties included?
    • All companies based in France must pay a 20% tax per report. The same applies to all individuals based in the EU. All EU companies must supply their VAT number when purchasing to avoid this charge.
    • I’m not satisfied. Can I be refunded?
    • No. Once your order has been processed and the publisher has received a notification to send you the report, we cannot issue any refund or cancel any order. As these are not ‘traditional’ products that can be returned, reports that are dispatched are considered to be ‘consumed’.
  • User license
    • The license that you should acquire depends on the number of persons that need to access the report. This can range from Single User (only one person will have the right to read or access the report), or Department License (up to 5 persons), to Site License (a group of persons based in the same company location), or Corporate License (the entire company personnel based worldwide). However, as publishers have different terms and conditions, we can look into this for you.
Purchase Reports From Reputable Market Research Publishers
Biomarkers: Discovery Techniques and Applications – A Global Market Overview

Biomarkers: Discovery Techniques and Applications – A Global Market Overview

  • $ 4860
  • August 2019

A more focused discovery process using proteins as biomarkers for various diseases has been in the development stage for quite some time now. The recent years have witnessed a more targeted approach in ...

Liver Cancer Diagnostic Tests - Medical Devices Pipeline Assessment, 2019

Liver Cancer Diagnostic Tests - Medical Devices Pipeline Assessment, 2019

  • $ 4000
  • November 2019

Liver Cancer Diagnostic Tests - Medical Devices Pipeline Assessment, 2019SummaryMedical Devices sector report, “Liver Cancer Diagnostic Tests - Medical Devices Pipeline Assessment, 2019" provides an ...

Global Biomarker Partnering Terms and Agreements 2014-2019: Deal trends, players and financials

Global Biomarker Partnering Terms and Agreements 2014-2019: Deal trends, players and financials

  • $ 2995
  • November 2019

The Global Biomarker Partnering Terms and Agreements 2014-2019: Deal trends, players and financials report provides comprehensive understanding and unprecedented access to the biomarker partnering deals ...


ref:plp2018

Reportlinker.com © Copyright 2019. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on